安旭生物: 安旭生物2024年年度股东大会会议资料

Core Viewpoint - The 2024 Annual General Meeting of Hangzhou Anxu Biotechnology Co., Ltd. will address various proposals including the work reports of the Board of Directors and Supervisors, the annual financial report, and profit distribution plans, reflecting the company's operational performance and governance structure [1][6][22]. Group 1: Meeting Procedures and Regulations - Shareholders must provide identification and authorization documents to attend the meeting, ensuring orderly conduct and protection of shareholder rights [2][4]. - The meeting will combine on-site and online voting, with specific time slots for each voting method [4][5]. - The agenda includes sign-in, introduction of attendees, reading of meeting rules, and sequential voting on proposals [5][6]. Group 2: Financial Performance - The company reported a net profit attributable to shareholders of 192.30 million yuan, a 35.85% increase year-on-year, while the net profit after deducting non-recurring items decreased by 27.6% to 37.90 million yuan [8][23]. - Total assets as of the end of 2024 were 5.77 billion yuan, a slight decrease of 0.35% compared to the previous year [23][24]. - The company achieved a revenue of approximately 540.70 million yuan, reflecting a growth of 7.42% from the previous year [24]. Group 3: Governance and Oversight - The Board of Directors and Supervisors have conducted their duties in accordance with relevant laws and regulations, ensuring compliance and protecting shareholder interests [17][22]. - The independent directors provided reports summarizing their activities and recommendations for the upcoming year, emphasizing their role in corporate governance [6][13]. - The Supervisory Board confirmed that the company operated within legal frameworks and that there were no violations or irregularities in financial reporting [20][22]. Group 4: Future Plans - The company aims to enhance its governance structure and internal controls, focusing on sustainable development and maximizing shareholder value [14][15]. - Plans for 2025 include advancing technological innovation, expanding product lines, and improving operational efficiency to strengthen market competitiveness [14][15].